Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 Exhibit 3.1
- 4.4 Exhibit 4.4
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 10.9 Exhibit 10.9
- 10.10 Exhibit 10.10
- 10.11 Exhibit 10.11
- 10.12 Exhibit 10.12
- 10.13 Exhibit 10.13
- 10.14 Exhibit 10.14
- 10.15 Exhibit 10.15
- 10.16 Exhibit 10.16
- 10.17 Exhibit 10.17
- 10.18 Exhibit 10.18
- 10.19 Exhibit 10.19
- 10.20 Exhibit 10.20
- 10.21 Exhibit 10.21
- 10.22 Exhibit 10.22
- 10.23 Exhibit 10.23
- 10.24 Exhibit 10.24
- 10.25 Exhibit 10.25
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- EX-FILING FEES Ex-filing Fees
Associated filings
GPCR similar filings
Filing view
External links
Exhibit 107
Calculation of Filing Fee Table
Form S-1
Structure Therapeutics Inc.
Table 1 - Newly Registered Securities
Security |
Security Class Title(1) |
Fee Calculation Rule |
Amount |
Proposed | Maximum Price(2)(3) |
Fee Rate |
Amount of Registration |
Equity | Ordinary Shares, $0.0001 par value per share | Rule 457(o) | — | — | $100,000,000 | 0.00011020 | $11,020 |
Total Offering Amounts | — | $100,000,000 | — | $11,020 | |||
Total Fee Offsets | — | — | — | — | |||
Net Fee Due | — | — | — | $11,020 |
(1) | These Ordinary Shares are represented by American depositary shares, or ADSs each of which represents Ordinary Shares of the registrant. ADSs issuable upon deposit of the Ordinary Shares registered hereby are being registered under a separate registration statement on Form F-6. | |
(2) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. | |
(3) | Includes the aggregate offering price of additional Ordinary Shares represented by ADSs that the underwriters have the option to purchase solely to cover over-allotments, if any. |